Log in
Enquire now
Inviragen

Inviragen

Inviragen is a company developing vaccines to prevent infectious diseases.

OverviewStructured DataIssuesContributors

Contents

inviragen.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Healthcare
Healthcare
Technology
Technology
Biotechnology
Biotechnology
Biology
Biology
Location
‌
Fort Collins, Colorado
AngelList URL
angel.co/inviragen
Pitchbook URL
pitchbook.com/profiles.../53465-50
Number of Employees (Ranges)
11 – 500
Investors
Charter Life Sciences
Charter Life Sciences
Venture Investors
Venture Investors
Phillip Private Equity
Phillip Private Equity
DUNS Number
141588801
Total Funding Amount (USD)
15,000,000
Latest Funding Round Date
October 6, 2009
Acquisition Transaction
‌
Acquisition of Inviragen by Takeda Pharmaceutical
Latest Funding Type
Series A
Series A
Patents Assigned (Count)
1
Wellfound ID
inviragen

Other attributes

Company Operating Status
Closed
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Inviragen

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.